Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Wilson L. Tang"'
Autor:
Daniel Seung Kim, Emily L. Chu, Emily E. Keamy-Minor, Ishan Dhananjay Paranjpe, Wilson L. Tang, Jack W. O’Sullivan, Yaanik B. Desai, Michael B. Liu, Elise Munsey, Kimberly Hecker, Isabella Cuenco, Beth Kao, Ellen Bacolor, Colleen Bonnett, Andrea Linder, Kathleen Lacar, Nancy Robles, Cindy Lamendola, Allysonne Smith, Joshua W. Knowles, Marco V. Perez, Masataka Kawana, Karim I. Sallam, Chad S. Weldy, Matthew T. Wheeler, Victoria N. Parikh, Heidi Salisbury, Euan A. Ashley, the Stanford Center for Inherited Cardiovascular Disease, Karim I Sallam, Chad S Weldy, Marco Perez, Joshua W Knowles, Jason Tso, Julia Platt, Chloe Reuter, Tia Moscarello, Ryan Murtha, Jennifer Kohler, Hannah Ison, Mitchel Pariani, Anusha Klinder, Priya Nair, Jennifer Marino, Ruchi Patel, Matthew T Wheeler, Euan A Ashley, Victoria N Parikh
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Mavacamten is a first-in-class cardiac myosin ATPase inhibitor, approved by the United States Food and Drug Administration for the treatment of hypertrophic cardiomyopathy with obstructive physiology (oHCM). Here, we present the real-world use of mav
Externí odkaz:
https://doaj.org/article/10cfc802d1ec46fb9a4e39b0fd818be9
Autor:
Hayk Barseghyan, Wilson L Tang, Emmanuèle Délot, Stanley F. Nelson, Emilie D. Douine, Matthew S. Bramble, Eva E. Segura, Miguel Almalvez, Eric Vilain, Allen Lipson, Hane Lee, Richard T. Wang
Publikováno v:
Genome Medicine
Genome Medicine, Vol 9, Iss 1, Pp 1-11 (2017)
Genome Medicine, Vol 9, Iss 1, Pp 1-11 (2017)
Background Massively parallel DNA sequencing, such as exome sequencing, has become a routine clinical procedure to identify pathogenic variants responsible for a patient’s phenotype. Exome sequencing has the capability of reliably identifying inher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2ab862c1a3570a23faac15190e8b039
http://europepmc.org/articles/PMC5655859
http://europepmc.org/articles/PMC5655859